EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related quality of life in patients with mycosis fungoides and Sézary syndrome: Real‐world data in Spanish patients (MICADOS Study)-Reference-Cited by-同舟云学术

EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related quality of life in patients with mycosis fungoides and Sézary syndrome: Real‐world data in Spanish patients (MICADOS Study)

Published:2022-07-07 Issue:4 Volume:1 Page:438-449
ISSN:2768-6566
Container-title:JEADV Clinical Practice
language:en
Short-container-title:JEADV Clinical Practice

Author:

Navarro Matilla Belén¹,Onteniente Gomis Mª del Mar²,Pujol Vallverdú Ramon M.³,Combalia Escudero Andrea⁴,Zapata Paz Irma⁵,Muniesa Montserrat Cristina⁶^ORCID,González Barca Eva⁷,Morillo Andújar Mercedes⁸,Pérez Ferriols Amparo⁹,Román Curto Mª Concepción¹⁰,Fernández de Misa Cabrera Ricardo¹¹^ORCID,Hospital Gil Mercedes¹²,Marín Niebla Ana¹³,Rios Rull Pablo J.¹⁴,de la Cruz Vicente Fátima¹⁵,Izu Belloso Rosa M.¹⁶,Martín García‐Sancho Alejandro¹⁷,Parera Amer M. Elisabet¹⁸,Córdoba Mascuñano Raúl¹⁹,Ramón Quiles María Dolores²⁰,Saus Carreres Ana²¹,del Campo García Raquel²²,Machan Salma²³^ORCID,Viguera Ester Pablo²⁴,Blanco Garnelo Julia²⁴,Soler López Begoña²⁵^ORCID,Ortiz Romero Pablo L.²

Affiliation:

1. Hematology Department Hospital Universitario Puerta de Hierro Madrid Spain

2. Department of Dermatology, Institute I + 12, CIBERONC, Medical School, Hospital Universitario 12 de Octubre Complutense University Madrid Spain

3. Dermatology Department Hospital del Mar Barcelona Spain

4. Dermatology Department Hospital Universitario Clínic i Provincial Barcelona Spain

5. Oncology Radiation Department Hospital Universitario Puerta de Hierro Madrid Spain

6. Dermatology Department Hospital Universitario de Bellvitge Barcelona Spain

7. Hematology Department Institut Catalá D'Oncología—Hospitalet Spain Barcelona

8. Dermatology Department Hospital Universitario Virgen del Rocío Sevilla Spain

9. Dermatology Department Hospital General Universitario de Valencia Valencia Spain

10. Dermatology Department Hospital General Universitario de Salamanca Salamanca Spain

11. Dermatology Department Hospital Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife (Islas Canarias) Spain

12. Dermatology Department Hospital Universitario Puerta de Hierro Madrid Spain

13. Hematology Department Hospital Universitario Vall d'Hebrón/VHIO Barcelona Spain

14. Hematology Department Hospital Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife Islas Canarias Spain

15. Hematology Department Hospital Universitario Virgen del Rocío Sevilla Spain

16. Dermatology Department Hospital de Basurto Bilbao Spain

17. Hematology Department Hospital General Universitario de Salamanca Salamanca Spain

18. Dermatology Department Hospital Son Llàtzer Palma de Mallorca (Islas Baleares) Spain

19. Hematology Department Hospital Universitario Fundación Jiménez Díaz Madrid Spain

20. Dermatology Department Hospital Clínico Universitario Valencia Spain

21. Hematology Department Hospital Clínico Universitario Valencia Spain

22. Hematology Department Hospital Son Llàtzer Palma de Mallorca (Islas Baleares) Spain

23. Dermatology Department Hospital Universitario Fundación Jiménez Díaz Madrid Spain

24. Medical Department Kyowa Kirin Farmacéutica, S.L. Madrid Spain

25. Medical Department E‐C‐BIO, S.L. Las Rozas (Madrid) Spain

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jvc2.39

Reference30 articles.

1. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

2. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

3. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.

4. Cutaneous T cell lymphoma‐mycosis fungoides and Sezary syndrome: an update;Parker S;Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia,2009

5. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017